Tech Company Financing Transactions
OVATION Pharmaceuticals Funding Round
Warburg Pincus, Atlas Venture and FirstMark Capital invested in a $60 million Series C funding round for OVATION Pharmaceuticals. The financing round closed on 7/24/2006.
Transaction Overview
Company Name
Announced On
7/24/2006
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Series C
Investors
Warburg Pincus (Lead Investor) (Stewart Hen)
Proceeds Purpose
The proceeds from this Series C round will enable us to advance the development and commercialization of our product pipeline and fuel our mission to become a leading specialty pharmaceutical company serving the CNS market.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
Four Parkway North 200
Deerfield, IL 60015
USA
Deerfield, IL 60015
USA
Phone
Website
Email Address
Overview
Prestwick Pharmaceuticals, Inc. is a product-based specialty pharmaceutical company engaged in the development and marketing of small molecule drugs for chronic diseases of the central nervous system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Aronin
Chief Financial Officer
Curtis Rhine
Vice President
Tim Cunniff
Vice President
Robert Holt
Vice President
Christopher Silber
Vice President
Bryan Stuart
Vice President
Samuel Yonren
Vice President
Sally Young
VP - General Counsel
Patrick Morris
VP - Human Resources
Lance Williams
VP - Operations
Marc Wipperman
VP - Product Management
Sean Nolan
Browse more venture capital transactions:
Prev: 7/24/2006: NextMedium venture capital transaction
Next: 7/24/2006: Kythera Biopharmaceuticals venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs